FY2019 Earnings Estimate for Henry Schein, Inc. (NASDAQ:HSIC) Issued By Piper Jaffray Companies

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Piper Jaffray Companies lowered their FY2019 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, November 5th. Piper Jaffray Companies analyst S. James now expects that the company will earn $3.46 per share for the year, down from their previous forecast of $3.48. Piper Jaffray Companies also issued estimates for Henry Schein’s Q4 2019 earnings at $0.92 EPS, Q1 2020 earnings at $0.89 EPS, Q2 2020 earnings at $0.91 EPS, Q3 2020 earnings at $0.94 EPS, Q4 2020 earnings at $0.99 EPS, FY2020 earnings at $3.73 EPS, Q1 2021 earnings at $0.96 EPS, Q2 2021 earnings at $0.98 EPS, Q3 2021 earnings at $1.02 EPS and FY2021 earnings at $4.02 EPS.

Other research analysts have also issued research reports about the stock. Cleveland Research restated a “hold” rating on shares of Henry Schein in a research report on Friday, November 1st. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b” rating in a research report on Monday, October 14th. William Blair lowered shares of Henry Schein from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 7th. BidaskClub lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Thursday, September 26th. Finally, Barrington Research restated a “buy” rating and issued a $75.00 price target on shares of Henry Schein in a research report on Wednesday. Six investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $73.50.

Henry Schein stock opened at $68.91 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.95 and a current ratio of 1.63. The firm has a market cap of $10.04 billion, a price-to-earnings ratio of 16.69, a price-to-earnings-growth ratio of 2.62 and a beta of 0.85. Henry Schein has a 1 year low of $56.58 and a 1 year high of $72.81. The firm’s 50 day moving average price is $63.16 and its two-hundred day moving average price is $65.35.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.04. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.52 billion. Henry Schein had a net margin of 4.66% and a return on equity of 15.93%. The firm’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 earnings per share.

Henry Schein declared that its board has approved a stock repurchase plan on Thursday, October 31st that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 4.3% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its stock is undervalued.

In other Henry Schein news, CEO Stanley M. Bergman sold 90,000 shares of Henry Schein stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $67.51, for a total transaction of $6,075,900.00. Following the transaction, the chief executive officer now directly owns 344,554 shares in the company, valued at approximately $23,260,840.54. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 6,856 shares of Henry Schein stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $66.96, for a total transaction of $459,077.76. Following the transaction, the insider now owns 242,190 shares in the company, valued at $16,217,042.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 123,655 shares of company stock worth $8,373,585. Corporate insiders own 1.06% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Enterprise Financial Services Corp grew its position in Henry Schein by 101.3% during the 3rd quarter. Enterprise Financial Services Corp now owns 483 shares of the company’s stock worth $31,000 after purchasing an additional 243 shares in the last quarter. Cullen Frost Bankers Inc. purchased a new position in shares of Henry Schein during the 2nd quarter valued at $36,000. Ibex Wealth Advisors purchased a new position in shares of Henry Schein during the 2nd quarter valued at $40,000. Meeder Asset Management Inc. purchased a new position in shares of Henry Schein during the 2nd quarter valued at $59,000. Finally, Rational Advisors LLC grew its holdings in shares of Henry Schein by 24.9% during the 2nd quarter. Rational Advisors LLC now owns 903 shares of the company’s stock valued at $63,000 after acquiring an additional 180 shares in the last quarter.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Article: Initial Public Offering (IPO)

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.